Based on the above results, we used 7 genes (ACSS1, ERO1A, GPC4, PKP2, TXN, MERTK, and ZNF292) to construct a risk model to predict the prognosis of NSCLC patients with radiotherapy or chemotherapy. The gene discussed is ERO1A; the disease is non-small cell lung carcinoma.